On March 1, Dashenlin (SH603233, stock price 22.).53 yuan, market value of 25.7 billion yuan) announced that the company's wholly-owned subsidiary, Maoming Dashenlin Chain Pharmacy ***hereinafter referred to as Maoming subsidiary) received the "Indictment" from the People's Procuratorate of Dianbai District, Maoming City, Guangdong Province on November 23, 2023, the defendant is a Maoming subsidiary, and the defendant is Ke Jinlong, one of the actual controllers of the company. At present, the case has been tried in the first instance and is being heard.
Xindingxi (data map).
Subsequently, Dashenlin issued a supplementary announcement, saying that Ke Jinlong was thereAugust 2023was subject to criminal detention, but the company erroneously believed that the matter had not had a significant impact on the company's production and operation, and because the case was still in the process of trial and had not yet been decided, the company did not accurately grasp the relevant information disclosure requirements and failed to make an announcement in a timely manner.
On August 18, 2023, the Maoming subsidiary received the Notice of Case Filing, and then on August 24, 2023, Ke Jinlong received the Notice of Detention and was detained on the same day. On November 23, 2023, Maoming Dashenlin received the "Indictment", according to which Ke Jinlong was placed in custody as early as July 14, 2023. From Ke Jinlong's criminal detention on August 24, 2023, to March 1, 2023, Dashenlin disclosed this matter190 days have passed.
On the evening of March 1, Lou Xiaoyun, a lawyer at Shanghai Haihui Law Firm, told the "Daily Economic News" reporter through WeChatThe company has committed an information disclosure violation.
Ke Jinlong is suspected of offering bribes by a unit
Dashenlin said that according to the "Indictment", the notice of filing the case of the Maoming subsidiary and Ke Jinlong's detention notice, the situation is as follows: the defendant Maoming subsidiary and the defendant Ke Jinlong are suspected of offering bribes by the unit; Defendant Ke Jinlong, as the directly responsible person in charge of the unit, specifically carried out the unit's bribery, and the People's Procuratorate of Dianbai District, Maoming City, Guangdong Province, initiated a public prosecution in accordance with relevant provisions. At present, the case has been tried in the first instance and is being heard.
Dashenlin said that the lawsuit involved the historical wholesale business of the Maoming subsidiary, and the company's main business was concentrated in the retail business of chain pharmacies; From 2020 to 2022, the company's sales to the customers involved in the case accounted for the proportion of the company's revenue. 20% and 015%, which is relatively low. The company also said that Ke Jinlong himself does not currently hold any management position in the company and does not participate in any of the company's business management affairs, and the matters involved in the litigation will not have a significant adverse impact on the company's normal production and operation.
The correspondent noted that on February 8 this year,Dashenlin issued an announcement on the resignation of the director, saying that the company recently received a written resignation report submitted by the company's director Ke Kangbao and director Ke JinlongDirector Ke Jinlong applied for resignation as a director of the fourth board of directors of the company, and also resigned as a member of the nomination committee of the fourth board of directors.
Currently,The actual controllers of Dashenlin are Ke Yunfeng, Ke Kangbao, and Ke JinlongAs of February 8 this year, the three of them held shares in listed companies. 16%；Among them, the cumulative number of pledged shares of Ke Jinlong and Ke Kangbao accounts for the proportion of their shares. 89%。Calculated according to the latest stock priceThe corresponding market value of the shares held by the three is 547.4 billion yuan, 402.2 billion yuan, 51$8.1 billion.
The three Ke brothers are Mao celebrities. Maoming is also the birthplace of the Great Ginseng Forest. In February 1999, the predecessor of Dashenlin, Maoming Dashenlin Pharmaceutical Chain, was established. Ke Jinlong, who is now prosecuted in accordance with the law on suspicion of bribery by a unit, is one of the original founders of Dashenlin.
In 2022, the company achieved an operating income of 2124.8 billion yuan, an increase of 26 over the same period last year78%, net profit attributable to shareholders of listed companies 103.5 billion yuan, an increase of 30 over the same period last year90%。During the reporting period, the company's stores have exceeded 10,000Reach 10.05 million, of which the number of franchise stores is 2007.
In the annual pharmacy ranking jointly released by "21st Century Pharmacy" and Minenet, Dashenlin won the third place in the "2021-2022 Top 100 Chinese Chain Pharmacies Direct Sales List" and the second place in the "2021-2022 China Top 100 Chain Pharmacies in Comprehensive Strength".
In October 2023, Ke Jinlong and Wang Chunchan also ranked 813th in the "2023 Hurun Report" with a wealth of 7.5 billion yuan.
*: National Business Daily (NBDNEWS).